MedPath

Evaluation of probiotics effect on quality of life and seizure attacks in patients with refractory epilepsy

Phase 4
Recruiting
Conditions
epilepsy.
Epilepsy and recurrent seizures
Registration Number
IRCT20221024056286N1
Lead Sponsor
Oroumia University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
75
Inclusion Criteria

patients with refractory epilepsy

Exclusion Criteria

Cause serious complications following drug use
Dissatisfaction with continuing the study
Non-epileptic seizures
History of status epilepticus in the last 12 months
Change in dose and type of antiepileptic drugs in the last 30 days
Probiotic consumption in the last 30 days
Chronic GI diseases, kidney or liver failure
lactose intolerance
Life expectancy less than 1 year
Presence of progressive neurodegenerative disease
Presence of any psychiatric disorder

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Quality of life score in Quality of Life in Childhood Epilepsy Questionnaire version 55. Timepoint: 3 months before and 3 month later. Method of measurement: Quality of life score in Quality of Life in Childhood Epilepsy Questionnaire version 55.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath